Skin Ageing

3

Review clinical trials related to Skin Ageing. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Efficacy of a Combined Oral and Topical Collagen Regimen Compared to Topical Collagen or Oral Collagen Regimens in Women With Skin Ageing Signs

This clinical study is conducted at one study site and in 165 women with visible signs of skin aging. It compares after 13 weeks the benefit of a combined oral collagen supplement and topical collagen serum regimen compared with oral collagen alone and topical collagen serum alone in reducing in women presenting visible signs of skin ageing .

Participants needed: 165
Trial details
Age: 45-60Biological sex: FemaleType: InterventionalSponsor: Vichy LaboratoiresUpdated: Mar 16, 2026
Eligibility criteria

Participant having signed an Informed Consent Form (ICF) before any trial relate... [+14]

Participant who is pregnant or who is breast feeding; [+17]

Status: Not yet recruiting

Examine Impact of Topical Application of Active Versus Placebo on the Skin Microbiome in Sensitive Skin.

The purpose of this study is to build insights to understand how the placebo and active impacts the skin microbiome in women with high skin sensitivity (SS10 \> 13) and sun exposure. Microbiome samples will be taken at baseline after 2 weeks of using the placebo (base without active) as a run-in period followed by the usage of placebo for an additional 4 weeks. The participants will then start the usage of active formula for an additional 8 weeks with microbiome samples collected at the 10-week and 14-week. This will allow us to observe how the microbiome changes over time after the product usage of both placebo and active formulations relative to the pre-regimen condition. In addition, headshot photos will be taken using the Haut AI application at each time point concurrent to the microbiome sample collection to examine changes in skin appearances after the regimen.

Participants needed: 45
Trial details
Age: 40-60Biological sex: FemaleType: InterventionalSponsor: AB Biotics, SAUpdated: Mar 6, 2026
Eligibility criteria

Women aged 40-60 among all ethnicities and Fitzpatrick scale. [+10]

Used any of the products to be tested in the claim study in the past 3 months. -... [+11]

Status: Not yet recruiting

Clinical Trial to Assess the Efficacy and Safety of a Cosmetic Product in Individuals Showing Signs of Cutaneous Aging.

This clinical study investigates the effects and safety of a topical cosmetic product containing postbiotics (Bifida ferment extract and Pediococcus ferment extract) in women aged 35-60 with visible signs of skin aging. The study is a 3-month, single-center, intra-subject controlled trial involving 45 Caucasian women with sensitive or normal skin. Participants will apply 1 ml of the product twice daily. Clinical evaluations will be conducted at baseline and at 1 month, 2 months, and 3 months, using validated dermatological scales and non-invasive instruments (AEVA3D, Mexameter®, MoistureMap®, Cutometer®, Tewameter®, Clarius®, Glossymeter®). Safety will be assessed through systematic monitoring of adverse events, with serious adverse events expected to remain below 1%. Subjective perception will be evaluated via structured questionnaires.

Participants needed: 45
Trial details
Age: 35-60Biological sex: FemaleType: InterventionalSponsor: AB Biotics, SAUpdated: Jan 15, 2026
Eligibility criteria

Female participants. [+10]

Pregnant or breastfeeding women. [+16]